Chimeric HIV‐1 and HIV‐2 lentiviral vectors with added safety insurance

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Medical Virology

• Publication date

  2007-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jmv.20767PMID 17177309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lentiviral-mediated delivery of siRNAs for antiviral therapy

  2006cited by this paper
• Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usage

  2005cited by this paper
• Lentiviral Vectors and Antiretroviral Intrinsic Immunity

  2005cited by this paper
• Newborn liver gene transfer by an HIV-2-based lentiviral vector

  2005cited by this paper
• MHC Class I-Specific Inhibitory Receptors on CD8 T Cells – Impact on HIV-specific Activity

  2005cited by this paper
• Unlocking the potential of the human genome with RNA interference

  2004cited by this paper
• Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences

  2004cited by this paper
• Lentiviral Vectors

  2004cited by this paper
• Factors Influencing the Titer and Infectivity of Lentiviral Vectors

  2004cited by this paper
• Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy.

  2003cited by this paper
• RNA interference targeting Fas protects mice from fulminant hepatitis

  2003cited by this paper
• Heterologous Human Immunodeficiency Virus Type 1 Lentiviral Vectors Packaging a Simian Immunodeficiency Virus-Derived Genome Display a Specific Postentry Transduction Defect in Dendritic Cells

  2003cited by this paper
• HIV-2 Vectors.

  2003cited by this paper
• Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

  2003cited by this paper
• Impact of the Central Polypurine Tract on the Kinetics of Human Immunodeficiency Virus Type 1 Vector Transduction

  2003cited by this paper
• Interfering with disease: opportunities and roadblocks to harnessing RNA interference

  2003cited by this paper
• HIV‐2 derived lentiviral vectors: Gene transfer in Parkinson's and Fabry disease models in vitro

  2003influential reference
• Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors

  2002cited by this paper
• Lentiviral Vectors

  2002cited by this paper
• Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.

  2001cited by this paper
• Lentiviral vectors.

  2000cited by this paper
• Human Immunodeficiency Virus Types 1 and 2 Differ in the Predominant Mechanism Used for Selection of Genomic RNA for Encapsidation

  1999cited by this paper
• Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors

  1999cited by this paper
• Nonreciprocal Packaging of Human Immunodeficiency Virus Type 1 and Type 2 RNA: a Possible Role for the p2 Domain of Gag in RNA Encapsidation

  1998cited by this paper
• Human Immunodeficiency Virus Type 2 Lentivirus Vectors for Gene Transfer: Expression and Potential for Helper Virus-Free Packaging

  1998cited by this paper
• Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.

  1996cited by this paper
• Human Immunodeficiency Virus Type 2 (HIV-2): Packaging Signal and Associated Negative Regulatory Element

  1995cited by this paper
• Human Immunodeficiency Virus Type 2 (HIV-2) Trans-Activator (Tat): Functional Domains and the Search for Trans-Dominant Negative Mutants

  1993cited by this paper
• Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate

  1990cited by this paper
• Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements.

  1988cited by this paper
• New human and simian HIV-related retroviruses possess functional transactivator (tat) gene

  1987cited by this paper
• Relation of HTLV-4 to simian and human immunodeficiency-associated viruses

  1987cited by this paper
• Molecular cloning and polymorphism of the human immune deficiency virus type 2

  1986influential reference
• Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

  1985cited by this paper

• PK15 cell line stably overexpressing IL2 enhances PCV2 replication

  2021cites this paper
• Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy.

  2020cites this paper
• Targeting tissue inhibitor of metalloproteinase 1 / 2 using a shRNA lentiviral system offers a novel treatment strategy against hepatic fibrosis

  2016cites this paper
• Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells

  2015cites this paper
• G Protein-Coupled Receptor Screening Assays: Methods and Protocols

  2015cites this paper
• Generation of Islet-like Cell Aggregates from Human Adipose Tissue-derived Stem Cells by Lentiviral Overexpression of PDX-1

  2015cites this paper
• Methods to immobilize GPCR on the surface of SPR sensors.

  2015cites this paper
• Investigating the physiological role of hypothalamic glucokinase in appetite and glucose homeostasis

  2013cites this paper
• Uso de vectores lentivirales para mediar la transfección del gen de la enzima n-acetil-galactosamina -6-sulfato-sulfatasa en células en cultivo

  2012cites this paper
• RNA interference and its role in the inhibition and cure of HIV/AIDS

  2011cites this paper
• Post-transcriptional inhibition of human immunodeficiency virus type 1 (HIV-1) using combinatorial RNA interference (RNAi) expression vectors

  2010cites this paper
• Use of HIV as a gene transfer vector.

  2009cites this paper
• State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.

  2009cites this paper
• Genetic-based therapies to select nonpathogenic variants of HIV-1.

  2007cites this paper
• Dévelappement de vecteurs lentiviraux non-intergratifs en vue du transfert de gènes dans le système nerveux central.

  2007cites this paper